An Institutional Review Board (IRB) and a Research Ethics Committee (REC) are two different types of bodies that are responsible for ensuring that research involving human subjects is conducted in an ethical and responsible manner. While the terms are often used interchangeably, there are some differences between an IRB and a REC.
In the United States, an IRB is a committee that is established by an institution, such as a university or hospital, to review and approve research protocols that involve human subjects. The IRB is responsible for ensuring that the study is designed and conducted in an ethical manner, that the risks to participants are minimized, and that the potential benefits of the study outweigh any potential harms. The IRB also monitors ongoing studies to ensure that they continue to meet ethical and safety standards.
In other countries, such as the United Kingdom, a Research Ethics Committee (REC) may have a similar role to an IRB. RECs are independent committees that review research proposals to ensure that they meet ethical and legal requirements, and that they are designed in a way that respects the rights and welfare of human participants. RECs may also provide ongoing monitoring and review of ongoing studies.
While there are some differences in the way that IRBs and RECs are structured and operate, their overall purpose is the same: to ensure that research involving human subjects is conducted in an ethical and responsible manner. Both IRBs and RECs may require researchers to submit detailed study protocols and obtain informed consent from study participants, and both may monitor ongoing studies to ensure that they continue to meet ethical and safety standards.
Share this story...
Real World Evidence (RWE) 101 – Patient Retention
RWE 101 - Patient Retention Long-term Real-World Evidence (RWE) studies face significant challenges when it comes to patient retention, for several reasons:[1] Time Commitment: Participants in RWE studies are [...]
Real World Evidence (RWE) 101 – Patient Recruitment
RWE 101 - Patient Recruitment Real-world evidence (RWE) is health care information derived from real-world data (RWD). It can be generated through various study designs or analyses, including pragmatic [...]
Real World Evidence (RWE) 101 – HARPER
RWE 101 - HARPER Regulatory agencies, health technology assessors, and payers are increasingly interested in studies that make use of real-world data to inform regulatory and other policy or [...]
Real World Evidence (RWE) 101 – STaRT-RWE
RWE 101 - STaRT-RWE START-RWE (Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies) was developed to address the need for improved transparency and [...]
Real World Evidence (RWE) 101 – Protocol Design and ISPE GPP
RWE 101 - Protocol Design and ISPE GPP The International Society for Pharmacoepidemiology (ISPE) Guidelines for Good Pharmacoepidemiology Practices (GPP) are a set of best practices for the conduct [...]
Real World Evidence (RWE) 101 – Protocol Design and Scientific Best Practices
RWE 101 - Protocol Design and Scientific Best Practices Designing a robust Real-World Evidence (RWE) study is crucial for generating reliable and valid insights that are acceptable to regulators. [...]







